About Us

Nghiem lab research team group photo

The Merkel Cell Carcinoma Collaborative (MC3) Institute was established to improve the lives of patients with MCC through excellent translational research. This institute is based out of the University of Washington and Fred Hutch Cancer Center.

Researcher working on a microscope
researcher working under fume hood
This is unpublished

Mission Statement

We collaborate to cure Merkel cell carcinoma. 

What we do 

We are a dedicated team of researchers, clinicians, and patient advocates united in the fight against Merkel cell carcinoma (MCC). 

Who We Are

UW Medicine UW Medicine logo

UW Medicine is an integrated clinical, research and learning health system with a single mission to improve the health of the public. More than 35,000 UW Medicine faculty, non-faculty practitioners and staff work to improve health for all people through excellence in clinical, research and education/training programs.

Fred Hutch Cancer Center Fred Hutch logo

Fred Hutch Cancer Center is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.

BACKGROUND

Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer, and its incidence is rising. To learn more visit our website, an educational resource managed by the MC3 Institute. 

Paul Nghiem
Paul Nghiem, MD, PhD, MC3 Institute Faculty Founder & Director

Paul Nghiem, MD, PhD, and his team at Fred Hutch Cancer Center and UW Medicine launched the Merkel Carcinoma Collaborative (MC3) Institute to accelerate and streamline research and improve treatment options for patients. We aim to provide structure for the 100+ MCC collaborators in Seattle and around the world. MC3 will manage and support scientific research projects, support training of junior scientists and clinicians, advocate for patient needs, and provide the best MCC clinical care in the world. 

Values

At the MC3 Institute, we are driven by five core values:

Patient-focused – We make decisions based on what is right for the patient. An MCC patient represents a community of people—we care for all of them. We treat patients like they are members of our own family. The challenges that patients experience guide our priorities.

Innovation – We believe in thinking outside the box and challenging the status quo. We are tenacious and driven to push the field forward. We believe that what we do will make a difference for patients. 

Collaboration – We collaborate because it is the most effective way to help our patients and advance the field. We believe team-based patient care is essential. We are approachable, curious, and available. We eagerly assist teams around the world and share data to accelerate progress. 

Education – We use the appropriate language for each audience to ensure understanding for everyone. We empower the world with information, so MCC patients have the best care options and live longer. We break down barriers (cost, lack of information, location) so patients have access to the best MCC resources. We train healthcare providers and scientists to be compassionate, ethical, and knowledgeable. 

Integrity – We are deliberate, accurate, and transparent. We do our homework and choose our problems carefully. We balance evidence-driven research with compassion. We never take for granted the precious gifts from patients (data, specimens, and funds) that make our progress possible.